RecruitingNCT03313024

Berlin-Brandenburg Pregnancy Cohort

Characterization of Immune Cell-trophoblast-interaction in Pregnancy Disorders


Sponsor

Charite University, Berlin, Germany

Enrollment

1,580 participants

Start Date

Sep 26, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria2

  • healthy pregnant women after giving informed consent
  • pregnant with diagnosis of preeclampsia, gestational hypertension or gestational diabetes

Exclusion Criteria3

  • infections
  • alcohol and drug abuse
  • manifest and chronic diseases

Locations(1)

Experimental and Clinical Research Center (ECRC)

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03313024


Related Trials